FRCSC

Viz.ai and UTMB Announce Collaboration to Accelerate Recruitment in the CHESS Study with Viz Subdural Solution

Retrieved on: 
четверг, мая 23, 2024
Software, Research, General Health, Pharmaceutical, Technology, Medical Devices, Infectious Diseases, Hospitals, Artificial Intelligence, Health Technology, Science, Neurology, Health, SDH, MPH, Bangladesh Technical Education Board, Patient, Chair, Randomized controlled trial, Viz, University, Ageing, Meta-analysis, Safety, FRCSC, DSM-IV codes, Systematic review, AI, Blood, MMAE, UTHealth School of Dentistry, Atrophy, University of Texas System, Workflow, Stroke, Professor, Brain, Chronic, CHESS, Triage, UTMB

In the CHESS trial, Viz.ai will notify investigators immediately when it detects a patient who has suspected SDH and meets the eligibility criteria for enrollment.

Key Points: 
  • In the CHESS trial, Viz.ai will notify investigators immediately when it detects a patient who has suspected SDH and meets the eligibility criteria for enrollment.
  • Study investigators can measure chronic bleeds4 and coordinate subject enrollment easily and securely through Viz.ai’s dynamic, mobile, HIPAA-compliant platform.
  • Management of chronic subdural hematoma with the subdural evacuating port system: Systematic review and meta-analysis.
  • https://pubmed.ncbi.nlm.nih.gov/33775320/
    4 Viz Subdural is currently available commercially for triage and notification.

ARC Fertility Named Finalist for Two Categories at FemTech World Awards 2024

Retrieved on: 
вторник, мая 7, 2024
Other Health, Professional Services, LGBTQ+, Consumer, HVAC, Hospitals, Health Insurance, Baby, Maternity, Women, Insurance, Manufacturing, Health, FACS, FRCSC, Femtech, Fertility, MD, FACOG, Patient, ARC, Wellbeing of Women

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its selection as a finalist in two categories at the recently held prestigious FemTech World Awards 2024 ceremony.

Key Points: 
  • ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its selection as a finalist in two categories at the recently held prestigious FemTech World Awards 2024 ceremony.
  • The FemTech Awards, recognizing outstanding achievements in women's health technology, shortlisted ARC for the "Company of the Year," sponsored by Guidea and "Gender Inclusive Employer," sponsored by Wellbeing of Women.
  • “Our FertilityNow app exemplifies the ability of FemTech to empower patients by providing a user-friendly platform that facilitates informed decision-making and personalized fertility journeys,” says Dr. Adamson.
  • “Through a strategic fusion of personalized care, virtual accessibility, evidence-based practices, user-friendly interfaces and cutting-edge apps, ARC Fertility continues to redefine the future of reproductive care in a concise and impactful manner.”

APEX Orthopedics Investments Launches to Revolutionize Foot and Ankle Orthopedic Industry

Retrieved on: 
вторник, мая 7, 2024
USD, University, Achilles tendon, MD, FRCSC, Foot, Ankle, Health, DPM, Anschutz Medical Campus, Investment, Nursing

AURORA, Colo., May 7, 2024 /PRNewswire/ -- APEX Orthopedics Investments, a groundbreaking asset management company dedicated to fostering innovation in the foot and ankle orthopedic sector, announces its establishment.

Key Points: 
  • AURORA, Colo., May 7, 2024 /PRNewswire/ -- APEX Orthopedics Investments, a groundbreaking asset management company dedicated to fostering innovation in the foot and ankle orthopedic sector, announces its establishment.
  • Led by a team of experts and located in the University of Colorado's Anschutz Medical Campus, APEX Orthopedics Investments is poised to transform orthopedic device development.
  • "Our mission at APEX Orthopedics Investments is to catalyze innovation within the foot and ankle orthopedic industry," stated Chris Banas, CEO and President of APEX Orthopedics Investments.
  • To learn more about APEX Orthopedics Investments and its transformative work, please visit www.APEXortho.net .

KARL STORZ and Well Lead Medical Announce Exclusive Agreement for Distribution of ClearPetra Stone-Removal System in the U.S.

Retrieved on: 
четверг, мая 2, 2024
Health Technology, Health, Medical Devices, Well, MIT Tech Talk, Urology, Kidney, American Urological Association, Marketing, Cleveland Clinic, MD, PCNL, Gynaecology, FRCSC, Stone, Booth, Master of Science, AUA, KARL, Research institute, Pharmaceutical industry

KARL STORZ United States announces an exclusive agreement with Well Lead Medical to offer the ClearPetra suction-evacuation ureteral access sheath in conjunction with KARL STORZ endoscopic visualization devices for comprehensive urinary stone management.

Key Points: 
  • KARL STORZ United States announces an exclusive agreement with Well Lead Medical to offer the ClearPetra suction-evacuation ureteral access sheath in conjunction with KARL STORZ endoscopic visualization devices for comprehensive urinary stone management.
  • “Our strategic collaboration with Well Lead Medical on ClearPetra represents a major step forward in stone management.
  • “The collaboration between Well Lead Medical and KARL STORZ represents a significant milestone in our commitment to advancing endourology.
  • During the show, KARL STORZ will be sponsoring a Tech Talk on May 4, 10:00–10:25 a.m., at Booth #1733.

ARC Fertility Captures Validation Institute 2023 Award for Cost Savings Report, Hosts Webinar

Retrieved on: 
вторник, апреля 30, 2024
Other Health, Professional Services, LGBTQ+, Consumer, Hospitals, Advocacy Group Opinion, Parenting, Health Insurance, Baby, Maternity, Insurance, Health, Public Policy, Government, Fertility, Twin, ARC, MD, Parent, Level 1, FACS, FRCSC, Patient, Validation, Mother, FACOG, Woman, Nursing

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its recognition by the Validation Institute with the 2023 Award for its exceptional cost savings report.

Key Points: 
  • ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its recognition by the Validation Institute with the 2023 Award for its exceptional cost savings report.
  • In conjunction with this achievement, David Adamson, MD, FRCSC, FACOG, FACS, Founder and CEO, ARC Fertility, will be presenting a webinar with the Validation Institute on Tuesday, May 7, 2023, at 1:00 pm ET.
  • "Receiving the Validation Institute 2023 Award underscores our dedication to delivering tangible results and cost savings for employers and families," says Dr. Adamson.
  • The Validation Institute awarded ARC Fertility the prestigious Level 1 validation for savings achieved, validating the effectiveness of its infertility care.

National Infertility Awareness Week: ARC Fertility Supports Family Building Act, Advocates Alongside RESOLVE and American Society for Reproductive Medicine

Retrieved on: 
понедельник, апреля 22, 2024
LGBTQ+, Professional Services, Family, Consumer, Hospitals, Advocacy Group Opinion, Health Insurance, Parenting, Baby, Maternity, Insurance, Congressional News, Views, Health, Public Policy, Government, Congress, Fertility, NIAW, ARC, Infertility, MD, Member of Congress, Partnership, Senate, FACS, IVF, FRCSC, Observation, Reproductive medicine, Patient, Legislation, Society, Access, ASRM, FACOG, Organization

ARC® Fertility , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly recognizes National Infertility Awareness Week ® (NIAW), an event founded by RESOLVE in 1989.

Key Points: 
  • ARC® Fertility , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly recognizes National Infertility Awareness Week ® (NIAW), an event founded by RESOLVE in 1989.
  • “During this significant observation, ARC Fertility also reaffirms its commitment to supporting legislative measures that enhance access to family-building services,” says David Adamson, MD, FRCSC, FACOG, FACS, Founder and CEO, ARC Fertility.
  • “We proudly announce our support for the Access to Family Building Act sponsored by U.S.
  • ARC Fertility has a longstanding history of collaboration with RESOLVE and other advocacy organizations in the field of reproductive health.

ARC Fertility Teams Up with Leapfrog for High-Value Family-Forming Benefits Webinar, Invites Self Insurance Stakeholders to Attend

Retrieved on: 
вторник, марта 5, 2024
Other Health, LGBTQ+, Professional Services, Family, Data Management, Consumer, Technology, Parenting, Baby, Maternity, Insurance, Women, Finance, Health, FACS, American Medical Women's Association, ROI, ARC, Fertility, FRCSC, Consultant, CFOS, FACOG, AMWA, Languages of Ethiopia, MPH, Patient safety, Publication, VOI, Face, Partnership, Management

In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.

Key Points: 
  • In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.
  • David Adamson, MD, FRCSC, FACOG, FACS, Founder and CEO, ARC Fertility, and Eliza Chin, MD, MPH, Executive Director, American Medical Women's Association (AMWA), will lead the discussion.
  • ARC Fertility is set to guide CEOs, CFOs and corporate human resources (CHRs) through the intricate landscape of family-forming benefits.
  • Drawing from our experience, we will explore the challenges employers face and the benefits of a flexible and affordable family-forming benefits solution.

Limmi appoints nationally recognized cancer researcher, Dr. Kader, to its Board of Directors

Retrieved on: 
вторник, марта 5, 2024
Advisory board, Doctor of Philosophy, MD, Urinary diversion, Bladder cancer, FRCSC, Genomics, Risk, Patient, Big data, UC San Diego Health, Deep learning, UCSD, Prostate cancer, Pharmaceutical industry

"We're in a desperate need at this time for solutions like the one Limmi is offering.

Key Points: 
  • "We're in a desperate need at this time for solutions like the one Limmi is offering.
  • states Professor Kader , and continues, "As a surgeon scientist, I made a discovery regarding genetic risk in prostate cancer.
  • In addition to being a board-certified urologist who specializes in detecting, treating, and preventing prostate cancer, Dr. Kader is nationally recognized for his expertise in performing robot-assisted radical cystectomy and urinary diversion for patients with bladder cancer.
  • He holds several patents for genetic discoveries related to early detection of prostate cancer.

Annunziato (Ned) Amendola, MD, FAAOS, FRCSC, DABOS, Named First Vice President of the American Academy of Orthopaedic Surgeons

Retrieved on: 
среда, февраля 14, 2024
SAN, Humility, Ankle, ISAKOS, Orthopaedic sports medicine, Research, MD, Knee, Foot, FRCSC, International Society, Royal college, Annual general meeting, Faculty, University, Duke, Duke University, Sports medicine, AAOS, American Academy, Dentistry

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- North Carolina orthopaedic surgeon Annunziato (Ned) Amendola, MD, FAAOS, FRCSC, DABOS, division chief for sports medicine at Duke University, was named first vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.

Key Points: 
  • SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- North Carolina orthopaedic surgeon Annunziato (Ned) Amendola, MD, FAAOS, FRCSC, DABOS, division chief for sports medicine at Duke University, was named first vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.
  • He will assume the first vice president position following the AAOS 2024 Annual Meeting this week in San Francisco.
  • He received several orthopaedic research awards, including the Excellence in Research Award, the Cabaud Memorial Award and the O'Donoghue Award.
  • While there, he held the Kim and John Callaghan Endowed Chair in Sports Medicine before leaving for Duke University.

Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

Retrieved on: 
четверг, февраля 8, 2024
Technology, Hospitals, FDA, Health Technology, Cardiology, Software, Practice Management, Health, Data Management, Artificial Intelligence, Radiology, Viz, Neurology, Brain, FRCSC, NCCT, Food, Food and Drug Administration, ICH, AI, University, UTHealth School of Dentistry, MPH, Multimedia, Neurosurgery, Hospital, Stroke, Lateral ventricles, Disease, Intracerebral hemorrhage

“This technology, which marries precision with AI, is poised to transform how we approach intracerebral hemorrhage cases."

Key Points: 
  • “This technology, which marries precision with AI, is poised to transform how we approach intracerebral hemorrhage cases."
  • Intracerebral hemorrhage accounts for up to 15% of all strokes and has high morbidity and mortality rates, demanding swift response.
  • Accurate volume measurements of brain bleeds are crucial for assessing the severity of cases, monitoring progression, and planning treatment strategies.
  • Viz ICH Plus exemplifies our dedication to enhancing patient care by leveraging technology," stated Jayme Strauss, chief clinical officer at Viz.ai.